Article thumbnail

Bone tissue engineering with human stem cells

By Darja Marot, Miomir Knezevic and Gordana Vunjak Novakovic


Treatment of extensive bone defects requires autologous bone grafting or implantation of bone substitute materials. An attractive alternative has been to engineer fully viable, biological bone grafts in vitro by culturing osteogenic cells within three-dimensional scaffolds, under conditions supporting bone formation. Such grafts could be used for implantation, but also as physiologically relevant models in basic and translational studies of bone development, disease and drug discovery. A source of human cells that can be derived in large numbers from a small initial harvest and predictably differentiated into bone forming cells is critically important for engineering human bone grafts. We discuss the characteristics and limitations of various types of human embryonic and adult stem cells, and their utility for bone tissue engineering

Topics: Review
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum
  2. (2007). Adipose-derived stem cells for regenerative medicine. Circ Res
  3. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
  4. (2003). AG: Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fl uid shear forces.
  5. (2008). Ahmadbeigi N: Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaff old. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  6. (1998). An isolation and in vitro culturing method for human intraoral bone cells derived from dental implant preparation sites. Clin Oral Implants Res
  7. (2003). Bartold PM: Tissue engineering for bone regeneration using diff erentiated alveolar bone cells in collagen scaff olds. Tissue Eng
  8. (2002). Bone-grafting and bone-graft substitutes.
  9. (2003). Bongso A: Comparative evaluation of various human feeders for prolonged undiff erentiated growth of human embryonic stem cells. Stem Cells
  10. (2006). Bouhassira EE: Diff erentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells
  11. (2008). Bunnell BA: Longterm in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res
  12. (2008). Cao T: Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems.
  13. (2009). Cao X: TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med
  14. (2009). Cell Therapy cGMP Facilities and Manufacturing: Regulation of Cell Product Manufacturing and Delivery: a United States perspective.
  15. (2009). Chabannon C: Cell Therapy cGMP Facilities and Manufacturing: the Regulatory Situation for Academic Cell Therapy Facilities in Europe.
  16. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol
  17. (2006). Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells
  18. (2008). Chung HM: In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaff olds. Biomaterials
  19. (2006). Chung HM: Primary bone-derived cells induce osteogenic diff erentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun
  20. (2009). Composite chitosan/nano-hydroxyapatite scaff olds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng Part A
  21. (2005). D: Bioreactor cultivation of osteochondral grafts. Orthod Craniofac Res
  22. (2006). DE: Matrix elasticity directs stem cell lineage specifi cation. Cell
  23. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med
  24. (1999). Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast diff erentiation.
  25. (2003). Developmental regulation of the growth plate. Nature
  26. (2009). Ding S: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell
  27. (2008). Diseases of bone and mineral metabolism: Anatomy and ultrastructure of bone - histogenesis, growth and remodeling.
  28. (2005). DL: Infl uence of macroporous protein scaff olds on bone tissue engineering from bone marrow stem cells. Biomaterials
  29. (2006). DL: Porous silk fi broin 3-D scaff olds for delivery of bone morphogenetic protein-2 in vitro and in vivo.
  30. (1999). DR: Multilineage potential of adult human mesenchymal stem cells. Science
  31. (2009). Eff ects of pamidronate on primary human osteoblast-like cells. Transactions ORS
  32. (2008). Effi cient diff erentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. Reprod Biomed Online
  33. (2007). Elcin AE, Elcin YM: Eff ect of osteogenic induction on the in vitro diff erentiation of human embryonic stem cells cocultured with periodontal ligament fi broblasts. Artif Organs
  34. (2007). Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials
  35. FDA: Code of Federal Regulations Title 21, Part 1271 - Human cells, tissue, and cellular and tissue-based products [ scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271]
  36. (1997). Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology
  37. (2004). Fujikawa K: Osteogenic potential of human adipose tissuederived stromal cells as an alternative stem cell source. Cells Tissues Organs
  38. (2007). Gazit D: Review: geneand stem cell-based therapeutics for bone regeneration and repair. Tissue Eng
  39. (2007). Gellrich NC: Bone formation after sinus augmentation with engineered bone. Clin Oral Implants Res
  40. (1987). Gerasimov UV: Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diff usion chambers. Cell Tissue Kinet
  41. (2004). Griffi th LG: Engineering principles of clinical cell-based tissue engineering.
  42. (2001). Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng
  43. (2002). Holtom P: Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes.
  44. (2004). Howaldt HP: Autologous stem cells (adipose) and fi brin glue used to treat widespread traumatic calvarial defects: case report. J Surg
  45. (2005). I: In vitro osteogenic diff erentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann Surg
  46. (2007). I: Three-dimensional perfusion culture of human adipose tissue-derived endothelial and osteoblastic progenitors generates osteogenic constructs with intrinsic vascularization capacity. Stem Cells
  47. (2008). ISSCR: Guidelines for the Clinical Translation of Stem Cells.
  48. (1998). JM: Embryonic stem cell lines derived from human blastocysts. Science
  49. (2005). JM: The biology of bone grafting.
  50. (2007). Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell
  51. (2007). KL: Clinicalscale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem Cells
  52. (2004). LD: In vitro diff erentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng
  53. (1999). Ljunggren O: Three isolation techniques for primary culture of human osteoblast-like cells: a Acta Orthop Scand
  54. (2009). Loboa EG: Electrospun composite poly(L-lactic acid)/tricalcium phosphate scaff olds induce proliferation and osteogenic diff erentiation of human adipose-derived stem cells. Biomed Mater
  55. (2006). Luyten FP: Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum
  56. (2003). Making bone: implant insertion into tissue-engineered bone for maxillary sinus fl oor augmentation -a report. J Craniomaxillofac Surg
  57. (2007). Meinel L: Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaff olds. Biomaterials
  58. (2007). Mesenchymal progenitors able to diff erentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fi broblast-like cell populations. Stem Cells
  59. (2007). Mesenchymal stem cell ingrowth and diff erentiation on coralline hydroxyapatite scaff olds. Biomaterials
  60. (2008). Milligen FJ: Eff ect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cellbased therapies. Cell Tissue Res
  61. (2005). MK: Characterization and culture of human embryonic stem cells. Nat Biotechnol
  62. (2007). No 1394/2007 of the European Parliament and of the
  63. (2005). of 10AF, Rao M, Chakravarti A: Genomic alterations in cultured human embryonic stem cells. Nat Genet
  64. (2007). Oreff o RO: The control of human mesenchymal cell diff erentiation using nanoscale symmetry and disorder. Nat Mater
  65. (2008). Periosteal cells compared with autologous cancellous bone in lumbar segmental fusion.
  66. (1976). Periosteal cells in bone tissue engineering. Tissue Eng 2003, 9(Suppl 1):S45-64. Marot et al.
  67. (2001). PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells
  68. (2006). PG: Skeletal sitespecifi c characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals.
  69. (2004). Pioletti DP: Fetal bone cells for tissue engineering.
  70. (1999). Prockop DJ: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells.
  71. (2009). Reilly GC: Use of rapidly mineralising osteoblasts and short periods of mechanical loading to accelerate matrix maturation in 3D scaff olds. Bone
  72. (2001). Repair of large bone defects with the use of autologous bone marrow stromal cells.
  73. (1984). RG: Production of osteocalcin by human bone cells in vitro. Eff ects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res
  74. (2009). Rochet N: Human primary osteocyte diff erentiation in a 3D culture system. J Bone Miner Res
  75. (2006). RS: Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells
  76. (2008). S: Analysis of OPLA scaff olds for bone engineering constructs using human jaw periosteal cells.
  77. (2000). Schabus R: The eff ect of diff erent isolation techniques on human osteoblast-like cell growth. Anticancer Res
  78. (2009). Schichor C: Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res
  79. (2009). SL: Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A
  80. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell
  81. (1998). The cell and molecular biology of fracture healing.
  82. (2006). Thomson JA: Derivation of human embryonic stem cells in defi ned conditions. Nat Biotechnol
  83. (2005). Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus fl oor augmentation: an in vitro study. Clin Oral Implants Res
  84. (2006). Tissue-engineered bone for lateral alveolar ridge augmentation: a case report.
  85. (2004). Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg
  86. (2005). Tsiridis E: Bone substitutes: an update. Injury
  87. (2003). Tuan RS: Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells
  88. (2006). Two techniques for the preparation of cell-scaff old constructs suitable for sinus augmentation: steps into clinical application. Tissue Eng
  89. (2004). Volloch V: Matrix-mediated retention of osteogenic diff erentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials
  90. (2010). Vunjak-Novakovic G: Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A
  91. (2004). Vunjak-Novakovic G: Bone tissue engineering using human mesenchymal stem cells: eff ects of scaff old material and medium fl ow. Ann Biomed Eng
  92. (2008). Vunjak-Novakovic G: Eff ects of initial seeding density and fl uid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A
  93. (2010). Vunjak-Novakovic G: Engineering anatomically shaped human bone grafts.
  94. (2007). Vunjak-Novakovic G: Engineering cartilage and bone using human mesenchymal stem cells.
  95. (2008). Vunjak-Novakovic G: Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther
  96. (2008). Wang HL: Common implant-related advanced bone grafting complications: classifi cation, etiology, and management. Implant Dent
  97. (2007). Yamanaka S: Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell
  98. (2008). Zafi ropoulos GG: Use of engineered bone for sinus augmentation.
  99. (2004). Zwaka TP, Thomson JA, Andrews PW: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol